Skip over navigation
The Food and Drug Administration has now approved Quillivant XR (methylphenidate hydrochloride), the first once-daily, extended-release liquid methylphenidate available for patients with ADHD.
Sponsored Links
About these ads
Consumer Tips
©2010 WETA. All Rights Reserved. | Privacy Policy | Terms & Conditions | Site Index | Home
About LD OnLine | Contact Us |
LD Basics | ADHD Basics | Questions + Answers | Glossary | LD Topics
For Educators | For Parents | For Kids | Expert Advice | LD Resources | Yellow Pages | LearningStore
IDEA 2004 | Contributors | First Person | Newsletters | Calendar | En Español | Forums | How to Advertise
LD OnLine works in association with the National Joint Committee on Learning Disabilities (NJCLD). Learn more.
LD OnLine is an educational service of public television station WETA in Washington, D.C.
Visit WETA's educational web sites:
LD OnLine® is a registered trademark of WETA.
Stay informed! Subscribe to our e-mail newsletter.
